Search

Search bills, members, committees and pages...

TEVA PHARMACEUTICALS USA, INC.

15 federal lobbying filings, 2023 to 2026.

TEVA PHARMACEUTICALS USA, INC. is a registrant on 15 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Clients

1 who it filed for, by filings.

ClientFilingsReported
TEVA PHARMACEUTICALS USA INC15

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$1.5M
20255$3.9M
20244$2.3M
20234$2.1M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues15
TARTariff (miscellaneous tariff bills)7

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S.J.Res. 37A joint resolution terminating the national emergency declared to impose duties on articles imported from Can…7
H.R. 6888Trump Tariff Transparency Act3
S. 959Tariff Transparency Act of 20253

Lobbyists

Named on the filings.

LobbyistClientsFilings
BEENA PATEL115
COLMAN RAGAN115
MICHAEL BRZICA115

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2026 second_quarter$380KJul 17, 2026
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2026 first_quarter$1.1MApr 20, 2026
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2025 fourth_quarter$360KJan 14, 2026
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2025 third_quarter$460KOct 17, 2025
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2025 second_quarter$1.4MSep 4, 2025
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2025 second_quarter$1.4MJul 17, 2025
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2025 first_quarter$310KApr 18, 2025
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2024 fourth_quarter$360KJan 17, 2025
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2024 third_quarter$310KOct 18, 2024
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2024 second_quarter$250KJul 15, 2024
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2024 first_quarter$1.3MApr 19, 2024
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2023 fourth_quarter$250KJan 17, 2024
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2023 third_quarter$300KOct 18, 2023
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2023 second_quarter$1.3MJul 18, 2023
TEVA PHARMACEUTICALS USA INCTEVA PHARMACEUTICALS USA, INC.2023 first_quarter$250KApr 20, 2023